Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer

PHASE1,PHASE2

Phase

TERMINATED

Status

Enrollment

NIH

Sponsor class

Stopped This study was terminated after the first patient treated on study died as a result of the treatment.

Conditions

DRUG: in vitro tumor reactive, chimeric T cell receptor (CAR ) gene-transduced PBL plus IV aldesleukin
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Mesna

National Cancer Institute (NCI)